Patent Analysis
Patent Analysis
Sale
The microfluidic device market was valued at USD 12.84 billion in 2023. It is expected to grow at a CAGR of 19.80% during the forecast period of 2024-2032 and attain a market value of USD 65.29 billion by 2032.
Microfluidic technologies for diagnostic applications are expected to grow due to increasing demand for point of care testing, technology has revolutionized drug discovery, and diagnostic testing and expanding applications areas such as infectious disease, genetic testing, and cancer biomarker detection. Moreover, the advancement in detection technologies is also impacting the market and the development of these advanced technologies including PCR amplification has impacted the patent landscape.
The microfluidic technologies for diagnostic applications patent landscape report provides comprehensive and in-depth analysis of the patents in the industry. The key sections captured in the report for microfluidic technologies for diagnostic applications includes a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within microfluidic technologies for diagnostic applications technologies.
Microfluidic technology has multiple benefits as miniaturized devices allows processing and analyzing of small sample volumes, in the range of μL to pL. These devices are used for rapid detection of pathogens in case of infectious diseases. In cancer diagnostics, this technique helps in detection of cancer biomarkers for early diagnosis. These expanding applications in the diagnostic field have led to patent filings by the companies to protect their intellectual property rights.
Microfluidic technology involves the control and manipulation of fluids, within channels, typically ranging from tens to hundreds of micrometer dimensions. These devices are known for their small scale, which allows for the handling of small amounts of fluids. This miniaturization offers advantages including faster reaction times, reduced reagent consumption, and increased sensitivity in analyses.
This technology offers multiple benefits over conventionally sized systems. They allow the analysis of less volume of samples, chemicals and reagents. The applications of microfluidic technologies for diagnostic applications include genetic, infectious, oncology, blood coagulation, and cardiac pathology. The development of innovative technologies for microfluidic systems promotes commercialization of microfluidic technologies for diagnostic applications and the patent filing of these advanced technologies.
Advances in Point of Care Testing is Expected to Augment the Patent Industry Growth
The demand for point-of-care testing solutions is driving the patent landscape in microfluidic devices for diagnostic testing. Patents in this field focus on portable and user-friendly devices.
Microfluidic point-of-care devices rapidly detect diseases at lower cost. This technology has the potential to detect diseases and reduce the effects of disease. A huge progress has been made in applying microfluidic technology in the diagnostic field including POC testing. The combination of mobile sensors based on integrated microfluidic devices and smartphones is a successful example of microfluidics with POC technologies. Hence the development of these integrated technologies has led to an increase in patent filings by companies.
Advances in Microfabrication Techniques, such as Lithography, Expected to Augment the Patent Industry Growth
Fluigent has developed a series of microfluidic systems based on its patented FASTAB technology. This technology overcomes the fluid volume manipulation issues which is present in the current microfluidic control systems. This advanced technology features pressure driven flow control which allows a pulseless flow and greater responsiveness. Companies are actively filing patents to protect their innovations which is significantly impacting the patent landscape.
Expanding Pharmaceutical and Biotechnology Applications to Boost Patent Filings
The microfluidic technology for diagnostic application is growing due to expanding applications in diagnostics including genetics, and infectious diseases. Moreover, microfluidic platforms are used to detect biomarkers which are associated with various diseases. It facilitates early detection of disease and effective monitoring of treatment.
The expanding application signifies the need for patent registration. Companies are filing patents to protect inventions and impact the patent landscape significantly. For instance, the number of patents granted for microfluidic technologies for diagnostic applications increased from 2,639 in 2020 to 2,785 in 2021.
The report will cover the following sections in detail
Breakup by Product
Breakup by Application
The breakup based on applications includes genetic, infectious, oncology and cardiac pathology. The production of microfluidic devices is achieved through multiple fabrication methods. The four most common techniques are soft lithography, 3D bioprinting, photolithography and injection molding.
The detailed technological data will be provided for all specified segments classified in this report.
The United States is one of the leading jurisdictions for microfluidic technologies for diagnostic applications patents, having around 38,000+ patents. The presence of a robust legal framework and advanced research and development activities contributes to the patent landscape significantly for the region.
Among the players with microfluidic technologies for diagnostic applications patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Life Technologies Corp
Life Technologies Corporation, a ThermoFisher company founded in 2008, was formed by the merger of Invitrogen Corporation and Applied Biosystems Inc. The company holds patents in the field of microfluidic technologies for diagnostic applications.
Illumina Inc.
Illumina, Inc., founded in 1998, and headquartered in the United States, is engaged in the development, manufacturing, and marketing of integrated systems for the analysis of genetic variation and biological function. The company has filed various patents in the field of digital microfluidics.
Other companies include Broad Inst Inc., 10x Genomics Inc., Modernatx Inc., Hoffmann La Roche, Geneasys Pty Ltd., Bristol Myers Squibb Co, Illumina Inc., Sequenom Inc., Fluidigm Corp, Becton Dickinson Co, and Pacific Biosciences California Inc., among others.
The Microfluidic Technologies for Diagnostic Applications Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:
Scope of the Report | Details |
Analysis by Product |
|
Analysis by Application |
|
Key Players Mentioned |
|
Geographies Covered |
|
Global Microfluidic Devices Market
Global In-Vitro Diagnostics Market
Global Bacterial Disease Diagnostics Market
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Introduction
2 Executive Summary
3 Global Microfluidics Market Overview
3.1 Global Microfluidics Market Historical Value (2017-2023)
3.2 Global Microfluidics Market Forecast Value (2024-2032)
4 Global Microfluidics Market Segmentation
4.1 Global Microfluidics Market Share by Product
4.1.1 Market Overview
4.1.2 Device
4.1.3 Component
4.1.3.1 Chip
4.1.3.2 Sensor
4.1.3.3 Microneedle
4.1.3.4 Pump
4.1.3.5 Valve
4.1.3.6 Other
4.1.4 Others
4.2 Global Microfluidics Market Share by End User
4.2.1 Market Overview
4.2.2 Diagnostic Centre
5 Global Market Dynamics
5.1 Market Drivers and Constraints
5.2 Porter’s Five Forces Analysis
5.3 PESTEL Analysis
5.4 Industry Events, Initiatives, and Trends
5.5 Value Chain Analysis
6 Global Microfluidics for Diagnostic Applications Patent Landscape Analysis
6.1 Patent Distribution by Publication Year
6.2 Patent Distribution by Application Year
6.3 Patent Distribution by Priority Year
6.4 Analysis by Type of Patent
6.4.1 Granted Patents
6.4.2 Patent Application
6.4.3 Amended Application
6.4.4 Search Report
6.5 Analysis by Legal Status
6.5.1 Active
6.5.2 Pending
6.5.3 Expired/Discontinued
6.6 Analysis by Patent Jurisdiction
6.7 Analysis by Patent Age
6.8 Analysis by Cooperative Patent Classification (CPC) Codes
6.9 Average Time to Publish a Patent
6.9.1 By Entities
6.9.2 By Jurisdiction
6.9.3 By Technology
6.10 Analysis by Type of Entity (Academic and Non-Academic)
6.11 Analysis by Top Applicants
6.12 Analysis by Top Inventors
7 Global Microfluidics for Diagnostic Applications Patent Analysis by Technology
7.1 Total Patents by Top Technologies
7.2 Time Evolution of Patents by Technology
7.3 Emerging Technologies
7.4 Patent Segmentation, By Product
7.4.1 Time Evolution by Number of Patents
7.4.2 Time Evolution by Number of Patent Families
7.4.3 Analysis by Type of Entity (Academic vs Non-Academic)
7.4.4 Analysis by Top Applicants
7.4.5 Analysis by Top Inventors
7.5 Patent Segmentation, By Application
*Complete technology list will be provided in the report.
8 EMR Patent Valuation Analysis
8.1 Assessment Methodology
8.2 High Value Patents
8.3 Medium Value Patents
8.4 Low Value Patents
9 Global Microfluidics for Diagnostic Applications – Top 10 Players Patent Analysis
9.1 Top 10 Entities by Number of Patents
9.2 Analysis by Publication Year
9.3 Analysis by Application Year
9.4 Analysis by Priority Year
9.5 Analysis by Type of Patent
9.6 Analysis by Jurisdiction
9.7 Analysis by Cooperative Patent Classification (CPC) Codes
9.8 Analysis by Source of Innovation
9.9 Analysis by Forward and Backward Citations
9.10 Analysis by Legal Status
9.11 Analysis by Patent Age
9.12 Analysis by Key Inventors
9.13 Entity Dynamics
9.13.1 Analysis by Type of Player (Academic vs Non-Academic)
9.13.2 Analysis by Collaboration
9.13.3 Analysis by Technology
9.13.4 Newcomers
9.13.4.1 Start-up Companies
9.13.4.2 Established Companies
10 Patent Profile of Key Players
10.1 Life Technologies Corp
10.1.1 Product Portfolio
10.1.2 Patent Portfolio by Patent Families
10.1.3 Time Evolution of Patents
10.1.4 Geographical Patent Coverage
10.1.5 Patent Analysis by Technology
10.1.6 Patent News and Developments
10.1.7 Financial Analysis
10.1.8 SWOT Analysis
10.2 Broad Inst Inc.
10.3 10x Genomics Inc.
10.4 Modernatx Inc.
10.5 Illumina Inc.
11 Future Trends
12 Global Microfluidics Landscape (Additional Insight) *
12.1 Global Microfluidics: Developers Landscape
12.1.1 Analysis by Year of Establishment
12.1.2 Analysis by Company Size
12.1.3 Analysis by Region
12.2 Global Microfluidics: Product Landscape
12.2.1 Analysis by Product
*Additional insights are not provided in the standard report.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.